The collection
is approved contingent upon the following terms of clearance. We
recognize the new paperwork requirements for suppliers and
providers. After extensive review, OMB approves the collection for
12 months. During this period, CMS will monitor the paperwork
burden required of providers and suppliers to determine if the
paperwork requirements impose any unnecessary burden on the
industry and/or need to be revised in order to improve the utility
of the information. Upon resubmission to OMB, CMS will solicit
public comments and report to OMB on its findings during the 12
month period.
Inventory as of this Action
Requested
Previously Approved
10/31/2007
36 Months From Approved
10/31/2006
37,400
0
37,400
37,400
0
37,400
0
0
0
Through CMS-3017-IFC, the CMS provides
further guidance with respect to the prescribing of and payment for
Power Mobility Devices. This rules defines the term power mobility
devices as power wheelchairs and power operated vehicles. CMS is
seeking approval for the collection requirements associated with
this rule. Specifically, we are seeking OMB approval for the
burdens associated with the doctor's prescription, and the
transmission of the patient's medical record from the physician to
the DME supplier, and the recordkeeping requirement imposed on the
suppliers that retain copies of...
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.